APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection
Links shared publicly online about this topic.
- 407total visits
APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection
APP Pharmaceuticals, Inc., (APP) announced that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorecta
View full resource at medicalnewstoday.com
Tags: Colorectal Cancer Medication, Pharma, Camptosar
Most Recently Shared on March 28, 2011 at 11:05 am By:
APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection http://mnt.to/3SNx #publichealth
Also Shared By:
FDA MedWatch - Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant - Drugs.com MedNews
drugs.com — “AUDIENCE Oncology, Pharmacy, Risk Manager ISSUE APP Pharmaceuticals, Inc. issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection due to th” View full resource at drugs.com
Most Recently Shared on March 28, 2011 at 5:06 pm By:
Drugs and Devices OW OW Health
FDA MedWatch - Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant: AUDIENCE: Oncolo... http://bit.ly/fhbqSE #drug
Advertisement
MNT Colorectal Canc
@mnt_colorectal
APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection http://mnt.to/3SNx #colorectalcancer
1 year ago...